VRC01LS

Customer Review

Based on 1 Customer Validation

VRC01LS is a humanized monoclonal antibody inhibitor targeting the CD4-binding site of HIV-1 envelope glycoprotein (Env). VRC01LS blocks the binding of HIV-1 to host cell CD4 receptor, inhibiting viral entry. VRC01LS is promising for research of HIV-1 infection.

For research use only. We do not sell to patients.

  • Purity: 98.78%
  • Molecular Weight:145.94 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All HIV Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00